The SHFJ is a research center dedicated to molecular and functional non-invasive imaging for clinical and preclinical research in oncology, neurology, neurodegenerative disease and psychiatry. The facility includes a nuclear medicine unit and is located in Orsay's Hospital area (near Paris).
<div class="ExternalClass0CEECC93DD5C417A9817D8E54EA099C7"><p>Molecular Imaging Research Center is a preclinical research installation created by the CEA and INSERM. This installation, consists of a group of platforms dedicated to the development of animal models pertinent to human diseases.</p></div>
NeuroSpin is a research center built to develop and validate neuroimaging using ultra-high Magnetic Field headed by Dr. Denis Le Bihan, a Member of the French Academy of Sciences. It was opened on January 1st 2007. The center is recognized as a large infrastructure, for biomedical imaging, such as the CERN in Genève. It is a shared imaging facility with unique imaging devices,. An 11.7T MRI scanner for human will be installed in 2016, one of the first in the world.
The Institute of Biomedicale Imaging take part in three projects: CATI, INUMAC project and Human Brain Project.
Toutes les faits marquants de l'I²BM
Centre d’acquisition et de traitement des images
Founded in 2010, CATI, or Centre d'acquisition et de traitement des images in french, is a nationale service platform supporting more than 30 muticenter neuroimaging studies in the fields of neurodegenerative diseases and psychiatry (AD, Parkinson, Huntington, ALS, Bipolar, etc.) including several therapeutic trials.
CATI was born out of a consortium of neuroimaging research laboratories who have complementary expertise : NeuroSpin (the French high-field MR imaging center of the CEA) and four teams located in La Pitié-Salpêtrière Hospital: ARAMIS and CENIR (the neuroimaging analysis research team and the neuroimaging platform of the Brain and Spine Institute), IM2A (the Institute for Memory and Alzheimer's disease) and LIB (an INSERM/UPMC unit focusing on research on functional imaging).
Building upon a large network of harmonized imaging facilities, the platform monitors acquisitions and performs centralized image analysis from a wide portfolio covering most of the MRI/PET/SPECT modalities. A machine learning service targetting biomarkers can be provided on demand following the needs. Raw data and analyses are delivered through a web service to the study's consortium according to the requests of the PI. Thanks to the harmonization of imaging acquisitions and analyses across studies and pathologies, the platform fosters collaborations in order to speed-up the emergence of research projects at the scale of big data.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.